Canada markets closed

IBEX Technologies Inc. (IBT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4600-0.0050 (-1.08%)
At close: 09:34AM EDT
Full screen
Previous Close0.4650
Open0.4600
Bid0.4400 x 0
Ask0.4750 x 0
Day's Range0.4600 - 0.4600
52 Week Range0.2700 - 0.6000
Volume5,000
Avg. Volume14,317
Market Cap11.419M
Beta (5Y Monthly)0.33
PE Ratio (TTM)7.67
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2022

    MONTRÉAL, Québec, June 10, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the nine months ended April 30, 2022. “We are pleased with the continued growth in sales, driven by strong sales of heparinase-based products, as well as by the sales of aryl-acyl amidase, a product used in tests for acetaminophen poisoning; and also with the continued strengthening of the Company’s balance sheet” said Paul Baehr, IBEX P

  • GlobeNewswire

    IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2022

    MONTRÉAL, March 17, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the six months ended January 31, 2022. “We are pleased with the continued growth driven by strong sales of heparinase-based products,” said Paul Baehr, IBEX President & CEO “and with the continued strengthening of the Company’s balance sheet. We foresee the trend to continue for the balance of the fiscal year.” Note: All figures are in Canadian

  • GlobeNewswire

    IBEX Announces Results of Annual Meeting

    MONTREAL, Feb. 17, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that all six nominees listed in its management proxy circular dated January 4, 2022 were re-elected as directors at the Company’s annual and special meeting held today in Montreal. At the meeting, shareholders also approved a resolution ratifying, confirming and approving the “reload” of 527,008 common shares under IBEX’s Incentive Stock Option Plan and a resolut